Insider Trading: ViroPharma Inc (VPHM.O)
VPHM.O on Nasdaq
26.10USD
22 May 2013
26.10USD
22 May 2013
Price Change (% chg)
$0.24 (+0.93%)
$0.24 (+0.93%)
Prev Close
$25.86
$25.86
Open
$25.87
$25.87
Day's High
$26.73
$26.73
Day's Low
$25.84
$25.84
Volume
1,037,176
1,037,176
Avg. Vol
--
--
52-wk High
--
--
52-wk Low
--
--
| ROWLAND CHARLES A JR | Options Exercised: 12,715 | ||
| Trade Date: | Tuesday, 6 Mar 2012 | Price: | 29.49 |
| Title: | Chief Financial Officer | Shares Held: | 35,048 |
| Type Traded: | Direct | Net Change in Shares This Filing: | 17,923 |
Institutional Holders
| % Shares Owned: | 0.00% |
| # of Holders: | 221 |
| Total Shares Held: | 69,802,145 |
| 3 Mo. Net Change: | 952,384 |
| # New Positions: | 30 |
| # Closed Positions: | 28 |
| # Increased Positions: | 102 |
| # Reduced Positions: | 101 |
| # Net Buyers: | 1 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Vincent Milano |
49 | 2008 | Chairman of the Board, President, Chief Executive Officer |
Charles Rowland |
54 | 2012 | Chief Financial Officer, Vice President |
Daniel Soland |
54 | 2008 | Vice President, Chief Operating Officer |
John Kirby |
41 | 2012 | Chief Accounting Officer, Vice President |
Colin Broom |
57 | 2004 | Vice President, Chief Scientific Officer |
Robert Fletcher |
50 | 2011 | Vice President - Business Development and Project Management |
John Wolf |
43 | 2008 | Vice President, General Counsel, Secretary |
Thomas Doyle |
52 | 2008 | Vice President - Strategic Initiatives |
Robert Pietrusko |
64 | 2007 | Vice President - Global Regulatory Affairs and Quality |
Howard Pien |
54 | 2008 | Lead Independent Director |
Paul Brooke |
68 | 2001 | Independent Director |
William Claypool |
61 | 2003 | Independent Director |
Michael Dougherty |
53 | 2004 | Independent Director |
Robert Glaser |
58 | 1997 | Independent Director |
John Leone |
65 | 2006 | Independent Director |
Julie McHugh |
48 | 2012 | Independent Director |

